CoChat

A model for receptor–peptide binding at the glucagon‐like peptide‐1 (GLP‐1) receptor through the analysis of truncated ligands and receptors

Open access
Al‐Sabah, Suleiman, Donnelly, Dan · 2003 · British Journal of Pharmacology
Cited by 100

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

The receptor for glucagon‐like peptide‐1 (GLP‐1) can be activated by both its physiological hormone and a peptide discovered in the venom of the Gila Monster, exendin‐4, which shows promise as an antidiabetic agent. Exendin‐4 displays receptor‐binding properties not observed for GLP‐1. Firstly, exendin‐4 can be truncated by up to eight residues at its N‐terminus without a significant loss of affinity. Secondly, exendin‐4 maintains high affinity for the isolated N‐terminal domain of the receptor, suggesting that exendin‐4 makes additional contacts with this domain of the receptor, which nullify the requirement for ligand–receptor interactions involving the extracellular loops and/or transmembrane helices of the receptor's core domain. In order to further understand the nature of the receptor–peptide interaction, a variety of full length and truncated peptide analogues were used to quantify the contribution of each distinct region of exendin‐4 and GLP‐1 to receptor affinity. Our data show that, for both exendin‐4 and GLP‐1, the primary interaction is between the putative helical region of the peptide and the extracellular N‐terminal domain of the receptor. However, we demonstrate that the contribution to receptor affinity provided by the N‐terminal segment of GLP‐1 is greater than that of exendin‐4, while the C‐terminal nine residue extension of exendin‐4, absent in GLP‐1, forms a compensatory interaction with the N‐terminal domain of the receptor. We describe a peptide–receptor binding model to account for these data. British Journal of Pharmacology (2003) 140, 339–346. doi:10.1038/sj.bjp.0705453

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0705453

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 100

Metadata

Authors
Al‐Sabah, S., & Donnelly, D.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2003-09
Volume
140
Issue
2
Pages
339-346
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1982077841
Cited by
100
References
5
FWCI
0.86
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.